(Q55033361)

16 June 2018

title

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. (English)

1 reference

16 June 2018

1 reference

1 reference

Olli-Pekka Kallioniemi

16

1 reference

16 June 2018

author name string

Bubendorf L

1

1 reference

16 June 2018

Kolmer M

2

1 reference

16 June 2018

Kononen J

3

1 reference

16 June 2018

Koivisto P

4

1 reference

16 June 2018

Mousses S

5

1 reference

16 June 2018

Chen Y

6

1 reference

16 June 2018

Mahlamäki E

7

1 reference

16 June 2018

Schraml P

8

1 reference

16 June 2018

Moch H

9

1 reference

16 June 2018

Willi N

10

1 reference

16 June 2018

Elkahloun AG

11

1 reference

16 June 2018

Pretlow TG

12

1 reference

16 June 2018

Gasser TC

13

1 reference

16 June 2018

Mihatsch MJ

14

1 reference

16 June 2018

Sauter G

15

1 reference

16 June 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

16 June 2018

Journal of the National Cancer Institute

published in

1 reference

16 June 2018

volume

91

1 reference

16 June 2018

issue

20

1 reference

16 June 2018

page(s)

1758-1764

1 reference

16 June 2018

Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Use of a cDNA microarray to analyse gene expression patterns in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Serial analysis of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Xenografts of primary human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

IGF system components as prognostic markers in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Regulation of prostate cell growth by the insulin-like growth factor binding proteins and their proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Insulin-like growth factors and their binding proteins: biological actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Heat shock proteins increase resistance to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Large unphosphorylated aggregates as the active form of hsp27 which controls intracellular reactive oxygen species and glutathione levels and generates a protection against TNFalpha in NIH-3T3-ras cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Bcl-2 and Hsp27 act at different levels to suppress programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Hsp-27 has no diagnostic or prognostic significance in prostate or bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F91.20.1758

21 January 2018

Identifiers

DOI

10.1093/JNCI/91.20.1758

1 reference

16 June 2018

1 reference

16 June 2018